Wave Life Sciences WVE
NASDAQ WVE
$3.44 +0.03 (+0.88%)
As of: Nov 11, 2026 · 10:17 AM EST

Wave Life Sciences (WVE) Current Deferred Tax Liability (2016)

Updated

Analysis

Wave Life Sciences (WVE) Current Deferred Tax Liability (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Wave Life Sciences 672.50 Mn -1.27 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 774,000.00
Jun 30, 2016 25,000.00
API Access

Wave Life Sciences Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=WVE&period=max&api_key=YOUR_API_KEY